- Home
- RENB vs FMY Comparison
RENB vs FMY Comparison
Compare RENB & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- FMY
- Stock Information
- Founded
- RENB 2011
- FMY 2005
- Country
- RENB United States
- FMY United States
- Employees
- RENB N/A
- FMY N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- RENB Health Care
- FMY Finance
- Exchange
- RENB Nasdaq
- FMY Nasdaq
- Market Cap
- RENB 61.0M
- FMY 49.6M
- IPO Year
- RENB N/A
- FMY N/A
- Fundamental
- Price
- RENB $0.32
- FMY $12.07
- Analyst Decision
- RENB
- FMY
- Analyst Count
- RENB 0
- FMY 0
- Target Price
- RENB N/A
- FMY N/A
- AVG Volume (30 Days)
- RENB 683.6K
- FMY 10.1K
- Earning Date
- RENB 05-19-2025
- FMY 01-01-0001
- Dividend Yield
- RENB N/A
- FMY 6.98%
- EPS Growth
- RENB N/A
- FMY N/A
- EPS
- RENB N/A
- FMY N/A
- Revenue
- RENB N/A
- FMY N/A
- Revenue This Year
- RENB N/A
- FMY N/A
- Revenue Next Year
- RENB N/A
- FMY N/A
- P/E Ratio
- RENB N/A
- FMY N/A
- Revenue Growth
- RENB N/A
- FMY N/A
- 52 Week Low
- RENB $0.29
- FMY $10.71
- 52 Week High
- RENB $2.34
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- RENB 37.38
- FMY 51.49
- Support Level
- RENB $0.29
- FMY $11.95
- Resistance Level
- RENB $0.35
- FMY $12.11
- Average True Range (ATR)
- RENB 0.05
- FMY 0.13
- MACD
- RENB 0.01
- FMY 0.00
- Stochastic Oscillator
- RENB 18.83
- FMY 54.71
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.